AQI Certified Centers AQI Certified Centers, recognized and certified for providing excellence in Alzheimer's care. 3) Ray Dolby Brain Health Center Sutter Health 45 Castro Street, Suite 220 San Francisco, CA 94114

Certified Sites This link will get you to a map of the sites Abington Neurological Associates Dr. David Weisman 1151 Old York Rd, Suite 200 Abington, PA 19001 Aventura Neurologic Associates, LLC Dr. Julie Schwartzbard 21000 NE 28th Avenue, Suite 205 Aventura, FL 33180 Baptist Health: Marcus Neuroscience Dr. Gediminas Gliebus 670 Glades Road, Suite 300 Boca Raton, FL 33431 Baptist Health: North Little Rock Dr. Mark Pippenger 3401 Springhill Drive, Suite 490-A North Little Rock, Arkansas 72117 Barrow Neurological Institute Drs. Anna Burke, Marwan Sabbagh, Tom Finkelstein 240 W Thomas Rd, Phoenix, AZ 85013 Baylor University Drs. Cindy Marshall & Claudia Padilla 9101 N Central Expy, Dallas, TX 75225 Brain and Spine Center Dr. Hermant Pandey 4045 W Chandler Blvd, Bldg F, Chandler, AZ 85226 BrainLove Dr. Dani Cabral 801 W. Maryland Ave Phoenix, AZ 85013 Bristol Health Dr. Margarita Reyes 85 Beleden Gardens Dr Bristol, CT 06010 Broadlawns Medical Center Dr. Yogesh Shah 1801 Hickman Road Des Moines , 50314 Central Wyoming Neurology Michele Belveal 5820 E 2nd St, Casper, WY 82609 Colorado Neurological Clinic Dr. Adam Wolff 950 East Harvard Avenue, Suite 570 Denver, CO 80210 Georgetown University Dr. Raymond Turner 4000 Reservoir Road, NW Washington, DC 20057 Greater Milford Neurology Dr. Lisa Dayaw 327 West St Milford, MA 01757 Hattiesburg Clinic Dr. Ronald L. Schwartz 415 S. 28th Ave. 6th Floor Hattiesburg, MS 39401 Indiana University Dr. Jared Brosc h 355 W. 15th St., Suite 3200 Indianapolis, IN 46202 Kootenai Health Dr. Susan Melchiore, 1919 Lincoln Way, #110 Coeur d'Alene, ID 83814 Maine Health Dr. Jeffery Maneval 92 Campus Dr. Ste. B, Scarborough, ME, 04074 Memorial Healthcare Dr. Cara Leahy 819 North Shiawassee St 1st Floor, Owosso, MI 48867 MercyOne Genesis Dr. Kayla Ehrman 1351 W. Central Park Ave, Pavilion 1, STE 340 Davenport, IA 52804 Michigan Institute for Neurological Disorders Dr. Jonathan Fellows 28595 Orchard Lake Road • Ste 200 Farmington Hills, MI 48334 Missouri Memory Center Dr. Curtis P. Schreiber 1245 N Butterfield Rd suite c1, Bolivar, MO 65613 NeuroCare Center Dr. Ryan Drake 4048 Dressler Rd NW, Canton, OH 44718 Neurology Cente r of New England, PC Dr. Salvatore Napoli 9 Payson Rd Foxborough, MA 02035 The Neuron Clinic Dr. Jose Soria 838 Nordahl Rd, # 200, San Marcos, CA 92069 Northwell – Hofstra - Feinstein Dr. Luca Giliberto 611 Northern Blvd #150, Great Neck, NY 11021 Northwestern University Dr. Joshua G. Cahan 420 E. Superior St. Chicago, IL 60611 Norton Neuroscience Institute Dr. Gregory E Cooper 4915 Norton Healthcare Boulevard, #301 Louisville, KY 40241 Ohio State University Dr. Doug Scharre 6100 N Hamilton Rd, Westerville, OH 43081 Stanford Center for Memory Disorders Dr. Sharon Sha 453 Quarry Road, MC 5979 Palo Alto, CA 94304 Southern Neurology Dr. Raymond Schwartz 10 / 11 Kensington St Kogarah NSW 2217 Specialist Memory Services Dr. James Bice 1/935 Station St Box Hill North, 3129 SUNY Upstate Neurodegenerative Disorders Center Dr. Tinatin Chabrashvili 90 Presidential Plaza, Syracuse, NY, 13210 Sutter Health: Ray Dolby Brain Health Center Dr. Armen Moughamian 45 Castro St #220 San Francisco, CA 94114 Tallaght University Drs. Sean Kennelly, Aoife Fallon, Antoinette Oconnor, Sean O Dowd Tallaght University Hospital, Tallaght, Dublin 24, D24 NR0A Tokyo Metropolitan Institute for Geriatrics Dr. Atsushi Iwata 35-2 Sakae-cho,Itabashi-ku, Tokyo, 173-0015,Japan Toronto Memory Program Dr. Sharon Cohen 1 Valleybrook Dr, North York, ON M3B 2S7, Canada University Hospitals Cleveland Medical Center Dr. Mohamed Elkasaby 11100 Euclid Ave Bolwell 5th Floor, Cleveland, OH 44106 University of Kansas Drs. Ryan Townley, Jeff Burns 4350 Shawnee Mission Pkwy Fairway, KS 66205 University of Rochester Drs. Emily Clark, Anton Porsteinsson 919 Westfall Rd Bldg C, Ste 220, Rochester, NY 14618 University of Oklahoma Dr. Claire Delpirou Nouh 920 Stanton L. Young Blvd, Suite 2040 Oklahoma City, OK 73104 University of Toronto Dr. Carmela Tartaglia 399 Bathurst St. WW 5-449 Toronto, ON M5T 2S8 University of Washington Dr. Michael Rosenbloom 325 9th Ave Main Hospital, Seattle, WA 98104 University Texas Health Dr. Paul Schulz 1941 East Road, Suite 4358 Houston, TX 77054 West Virginia University Drs. Joseph Malone, Lauren Bojarski, Marc Haut 33 Medical Center Drive Morgantown, WV 26506 Virginia Commonwealth University Health System Dr. James “Trey” Bateman 417 N 11th St, Richmond, VA 23298

Symptomatic Treatments Obviously the focus of AQI are the AATs. But we can't neglect symptomatic management. Because maximizing patient's health means getting into the weeds, finding the worst aspects of their lives and making them better. We ask you to focus on: AChE-I for memory (not for MCI). Memantine for late disease. Brexpiprazole: FDA approved for agitation. Show a reluctance to use benzos, neuroleptics, and anti-seizure drugs in general for N-psych problems. Demonstrate knowledge about anti-cholinergic danger. Steer families away from quacks and frauds, ie., Prev@gen among many others. Behavioral approaches, caregiver coaching.

Terms and Conditions THIS WEBSITE IS NOT INTENDED TO BE MEDICAL SERVICES. IF YOU HAVE A MEDICAL EMERGENCY, GO TO THE EMERGENCY ROOM OF A LOCAL HOSPITAL OR DIAL 911 IMMEDIATELY. Welcome to our website (“the Site”). The Site is provided by The Alzheimer’s Quality Initiative, a Pennsylvania non-profit corporation (the “AQI”, “We”, “Us”, or “Our”) to help support the mission of AQI to build healthier lives, free of Alzheimer’s and Dementia. This Agreement is between AQI and you (“You” or “Your”). PLEASE READ THIS ENTIRE DOCUMENT. PRINT FOR YOUR RECORDS. THIS IS A BINDING LEGAL AGREEMENT BETWEEN YOU AND THE ALZHEIMER’S QUALITY INITIATIVE. By using this Site, You represent, acknowledge and agree that You have sufficient legal capacity to agree to these Terms, or, if You are under the age of majority in your jurisdiction (a “Minor”) that You are using the Site with the consent of Your parent or legal guardian and that You have received your parent’s or legal guardian’s permission to use the Site and agree to its Terms. If You are a parent or legal guardian of a Minor, You hereby agree to bind the Minor to these Terms and to fully indemnify and hold harmless the AQI if the Minor breaches any of these Terms. If You are located outside the United States and are not at least 13 years old, You may not use the Site at any time or in any manner or submit any information to the AQIor the Site. The Site is governed by United States law. If You are using the Site from outside the United States, please be aware that Your information may be transferred to, stored, and processed in the United States or other countries, depending on the location of the servers of AQI or AQI Suppliers. The data protection and other laws of the United States and other countries might not be as broad as those in your country. BY USING THE SITE, YOU CONSENT TO YOUR INFORMATION BEING TRANSFERRED TO OUR FACILITIES AND TO THE FACILITIES OF THOSE THIRD PARTIES WITH WHOM WE SHARE YOUR INFORMATION AS DESCRIBED IN THE AQI Privacy Policy & Standards and the AQI Privacy Statement. IF YOU ACCESS OR USE THE SITE OR ANY CONTENT FROM OUTSIDE THE UNITED STATES, YOU ARE SOLELY RESPONSIBLE FOR ALL U.S. AND OTHER EXPORT LICENSES AND GOVERNMENTAL CONSENTS RELATED TO SUCH ACCESS OR USE, AND TO ANY SUBSEQUENT RE-EXPORT OF ANY OR ALL OF THE SITE OR CONTENT. In addition, information that We publish on the internet may contain references or cross references to Our products, programs and services that are not announced or available in Your country. Such references do not imply that We intend to announce such products, programs, or services in Your country. 1. Content. 1.1. The Site and the entire contents of the Site, including, but not limited to, text, files, images, graphics,, illustrations, audio, video, and photographs on or offered through the Site (collectively, “Content”) are protected by intellectual property rights, including, as applicable and without limitation, copyrights, trademarks, patents, and other proprietary and intellectual property rights(“Intellectual Property Rights”). 1.2. Content and other resources including articles, blogs, body of knowledge, message boards, groups, videos, photo galleries and other materials posted on the Site, as well as ideas, suggestions, opinions, comments, and observations made by other users or provided to AQI, and any text, data, photographs, video, music, sound, chat, messages, files or other material provided to AQI or posted on the Site is not intended to represent the viewpoint of the AQI. AQI does not endorse any commercial product, service, individual, or company that may be mentioned on the Site. You agree that conversations provided by other Users are not to be shared beyond the Site without the express permission of that User. Many of the conversations are private in nature and it is not for another User to decide what may be made public. You agree not to market, solicit, or encourage others to purchase products, services, supplements, or treatments for personal financial gain or for commercial benefit. 1.3. AQI DOES NOT PROVIDE ANY SERVICES TO OR ON BEHALF OF ANY HEALTH CARE PROVIDERS, PHARMACEUTICAL COMPANIES, OR ANY HEALTH ADVICE OR ASSISTANCE TO YOU, AND DOES NOT CONTROL THE CONTENT OF ANY OTHER USER (each a “User” and collectively, “Users”), and is not a party to any discussions or interactions between or among Users that may be facilitated by the Site. AQI’s responsibilities are limited to providing access to the Site. 1.4. Any comments, feedback, information, or materials regarding the Site or Our products, services or technologies (collectively, “Feedback”) that You submit to Us become AQI’s property. By submitting Your Feedback to Us, You agree to assign, and hereby irrevocably assign to us, all right, title, and interest in and to the Feedback and all copyrights and other intellectual property rights embodied in such Feedback on a worldwide basis without any compensation or obligation to You. AQI will be free to use Your Feedback on an unrestricted basis. You hereby assign and waive, as set forth in applicable laws, any moral rights that You may have in or to the Feedback. 2. Ownership. AQI logos, service marks, page design, images, written information, audio, video, animations, software functions and features provided through it, (“the Services”) belong to the AQI. Except as stated in this Agreement, You are not granted a license or right, whether by implication, estoppel, or otherwise, in or to the Site or Content, or to any Intellectual Property Rights in or related to them. You may not modify, reproduce, perform, display, create derivative works from, republish, post, transmit, participate in the transfer or sale of, distribute, or in any way exploit any portion of the Site or Content. You agree that the Services are provided to You for the limited purpose of helping You manage personal information and that We retain all rights, title and interests, including copyright and other proprietary rights, in the Services and all material, including but not limited to text, images, and other multimedia data on the Site unless expressly indicated as belonging to another. 3. Trademarks. Unless otherwise labeled, all trademarks, service marks, logos, photos, images, avatars, banners, page headers, and any other branding elements displayed (collectively, the "Marks") are the property of AQI. Except as expressly set forth in this Agreement, You may not display, link to, or otherwise use the Marks. Additionally, AQI Marks, together with any revisions, updates or registered alternative marks—may not be used except with the express, prior written consent of AQI. 4. Privacy. 4.1. AQI Privacy Statement, available at this link, governs the Use of the Services. The terms of AQI’s Privacy Statement are incorporated into this Agreement. You agree that We may use all information provided by You on this web site for the purpose for which You provide the information, such as to complete a transaction or to register You for a program or communication at Your request. AQI is not required to secure any personal information You enter into the Services and You assume all risk of disclosure for any information entered, including unintended disclosure such as due to unauthorized access or monitoring of Your activities within the Services. You are free to delete Your personal information from the Services and stop using the Services at any time. 4.2. AQI CANNOT AND DOES NOT CONTROL ANY THIRD-PARTY CONTENT (INCLUDING WITHOUT LIMITATION ANY POSTINGS BY USERS OR THIRD PARTIES ON THE SITE), OR THE CONDITION, LEGALITY OR SUITABILITY OF ANY COMMUNICATIONS FACILITATED BY THE SITE. AQI SPECIFICALLY DISCLAIMS, TO THE EXTENT PERMISSIBLE BY LAW, ANY RESPONSIBILITY FOR ANY ACTION OR INACTION BY ANY USER OR OTHER PARTY IMPACTED BY THE SITE. By using the Site, You agree that any legal remedy or liability that You seek to obtain for actions or omissions of other Users, AQI Suppliers, or other third parties will be limited to a claim against the particular User, AQI Supplier, or other third party that caused You harm. YOU AGREE NOT TO ATTEMPT TO IMPOSE LIABILITY ON OR SEEK ANY LEGAL REMEDY FROM AQI WITH RESPECT TO OTHER USER, AQI SUPPLIER, OR THIRD-PARTY ACTIONS OR OMISSIONS TO THE EXTENT PERMISSIBLE BY LAW. 4.3. AQI assumes no responsibility for how You use or disclose any health information that may be made available to You through the Site. If You utilize the Site to upload or access health information, You are responsible for ensuring that the computer systems You use have appropriate security controls enabled and that You have accessed the Site through a secure connection. You expressly assume the risk of any unauthorized disclosure or intentional intrusion, or delay, failure, interruption, or corruption of data or other information that You transmit to or receive from the Site. You are solely responsible for providing, maintaining, and ensuring the compatibility of all hardware, software, electrical and other physical requirements necessary for Your access to and use of the Site. 4.4. If You provide information to third parties on or through Us (including to third party providers of products, software, services or content), You acknowledge that such third parties are not bound by AQI’s Privacy Policy and that such third parties may or may not have restrictions on the use of such information. You acknowledge that AQI is not responsible or liable for the use by any third party of Your information, including personal or confidential information.4.5 GDPR Compliance: For users within the European Union (EU) and the European Economic Area (EEA), AQI complies with the General Data Protection Regulation (GDPR) regarding the collection, use, and retention of personal information. We process personal data in accordance with lawful bases and respect the rights of data subjects under GDPR. If you transfer any personal information of third parties to AQI through the use of the Site, you must ensure you have the lawful right to do so, including obtaining any necessary consents or authorizations in accordance with applicable data protection laws. AQI implements specific safeguards and legal mechanisms, including Standard Contractual Clauses (SCCs), for the transfer of personal data outside of the European Economic Area in compliance with GDPR. 5. De-Identification of Data. We reserve the right to remove those elements of data that might be used to associate data with You or any other individual, or to “de-identify” the data We collect, and to use and share such de-identified data for furthering Our mission. Aggregated, de-identified data may also be used for health trend analysis, disease control, in assessing the effectiveness of various health programs, research, and for other data analytics and purposes. Depending on the circumstances, We may or may not charge third parties for this de-identified data. By using the Services, You grant Us the right to accept payment or other remuneration for such aggregated, de-identified data. We require parties with whom We share aggregated, de-identified data to agree that they will not try to make this information personally identifiable. 6. Restrictions on Use. 6.1. You agree not to copy, license, sell, transfer, make available or otherwise distribute the Services to any entity or person without prior written authorization from AQI. You agree to use Your best efforts to stop any unauthorized copying or distribution immediately after such unauthorized use becomes known to You. Without limiting its remedies for breach of this Agreement, We reserve the right to end any relationship with You if You violate these terms. We reserve the right at any time in Our sole discretion to modify, suspend, or discontinue the Site (or any portion thereof) with or without notice. You warrant that all information provided to Us through the Services is accurate and that the person providing the information is over the age of 18 years, legally able to enter this Agreement, authorized by the entity You represent to enter into this Agreement, and that you are permitted under the laws of Your local jurisdiction to do so. 6.2 We reserve the right to not post or to remove without prior notice any of Your Content that, in our sole discretion, violates this Agreement. You hereby represent and warrant to Us that You own all right, title, and interest in and to any Content that You provide or upload, or that You have sufficient rights, whether by implication, estoppel, or otherwise, to grant Us the rights discussed in this Section. By providing or uploading any Content, You grant Us a nonexclusive, royalty-free, perpetual, irrevocable, and fully sublicensable right to use, copy, store, reproduce, modify, display, adapt, publish, translate, create derivative works from, distribute, and display such Content throughout the world in any form, media, software, or technology of any kind. In addition, You waive all moral and economic rights in the Content and warrant that all moral rights applicable to such Content have been waived. You also grant AQI the right to use Your name in connection with the reproduction or distribution of such material. 6.3 We may modify, suspend, deactivate, or close Your account or otherwise stop providing any AQI Sites or application in whole or in part at any time and for any reason. We will not be liable to You or any third party for suspension or termination of any AQI Site, application, or Your account. You will not be able to access any information in Your account once Your access has been suspended or terminated or an AQI Site or AQI App itself has been shut down. YOU ARE RESPONSIBLE FOR MAKING SURE YOUR CONTENT AND OTHER INFORMATION YOU DESIRE IS PROPERLY BACKED UP SO YOU HAVE ACCESS TO IT IN THE EVENT OF LOSS, CORRUPTION, OR CESSATION OF ANY AQI SITE, AQI APP, OR TERMINATION OR SUSPENSION OF YOUR ACCOUNT. WE DO NOT EXPORT YOUR CONTENT, YOUR INFORMATION, OR OTHER DATA DURING YOUR USE OF THE SITE, OR PROVIDE YOUR CONTENT, INFORMATION, OR OTHER DATA TO YOU WHEN YOUR ACCOUNT IS CLOSED. 7. Representations and Warranties. 7.1 THE SITES, INCLUDING ANY CONTENT OR INFORMATION CONTAINED IN THE SITES AND ANY SITERELATED SERVICE, ARE PROVIDED "AS IS," WITH NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE OR NON-INFRINGEMENT. STATEMENTS OUTSIDE THE TERMS INCLUDING, WITHOUT LIMITATION, STATEMENTS REGARDING CAPACITY, SUITABILITY FOR USE OR PERFORMANCE, WHETHER MADE BY OUR EMPLOYEES, OTHER USERS, OR OTHERWISE, ARE NOT A WARRANTY OR PROMISE BY US, AND WE HAVE NO RESPONSIBILITY OR LIABILITY FOR ANY SUCH STATEMENTS. WE HAVE NO RESPONSIBILITY FOR THE TIMELINESS, DELETION, MISDELIVERY OR FAILURE TO STORE ANY COMMUNICATION, INFORMATION OR CONTENT.NEITHER AQI, NOR ANY OF OUR AFFILIATES, LICENSORS, OR SUPPLIERS WARRANT THAT THE SITE WILL CONTINUE TO BE PROVIDED, WILL FUNCTION AS DESCRIBED, CONSISTENTLY OR IN ANY PARTICULAR MANNER, WILL BE UNINTERRUPTED, ACCURATE, ERROR FREE, OR FREE OF HARMFUL COMPONENTS, OR WILL PROVIDE THE RESULTS YOU EXPECT. NEITHER WE, NOR ANY OF OUR AFFILIATES, LICENSORS, OR SUPPLIERS WILL BE RESPONSIBLE FOR (I) ANY ERRORS, INACCURACIES, OR SERVICE INTERRUPTIONS, INCLUDING POWER OUTAGES OR SYSTEM FAILURES; OR (II) ANY UNAUTHORIZED ACCESS TO OR ALTERATION OF, OR DELETION, DESTRUCTION, DAMAGE, OR LOSS OF, YOUR CONTENT OR ANY DATA, IMAGES, TEXT, OR OTHER INFORMATION OR CONTENT. WE MAY DISCONTINUE ALL OR ANY PART OF THE SITE, AND MAY CHANGE THE NATURE, FEATURES, FUNCTIONS, SCOPE, OR OPERATION OF THE SITE OR THE SERVICES AT ANY TIME AND FROM TIME-TO-TIME. 7.2 YOU ASSUME TOTAL RESPONSIBILITY AND RISK FOR YOUR USE OF THE SITE, SERVICES, AND ANY LINKED WEBSITES. YOUR SOLE REMEDY FOR DISSATISFACTION WITH THE SITE, SERVICES, CONTENT, OR INFORMATION, OR LINKED WEBSITES IS TO STOP USING THE SITE, SERVICES, CONTENT, OR INFORMATION OR LINKED WEBSITES. 7.3 YOU AGREE NOT TO ATTEMPT TO IMPOSE LIABILITY ON OR SEEK ANY LEGAL REMEDY FROM AQI WITH RESPECT TO OTHER USER, AQI SUPPLIER, OR THIRD-PARTY ACTIONS OR OMISSIONS TO THE EXTENT PERMISSIBLE BY LAW. 7.4 Some jurisdictions do not allow the disclaimer of warranties, so such disclaimers and exclusions may not apply to You. If any of the provisions of this Section are held to be void or unenforceable, such provisions shall be limited or eliminated to the minimum extent necessary and replaced with a valid provision that best embodies the intent of the Agreement. 8. Limitation of Liability. In no event is AQI liable to You or to any user of the Services or to any other person or entity for any direct, indirect, special, exemplary, or consequential damages, including lost profits. This limitation is effective whether based on breach of warranty, contract, negligence, strict liability, lost opportunity, or otherwise, arising under this Agreement or any performance under this Agreement, whether or not You had any knowledge, actual or constructive, that such damages might be incurred. In the event You are dissatisfied with, or dispute these terms of this Agreement or the Content, Your sole right and exclusive remedy is to terminate Your use even if that right or remedy is deemed to fail of its essential purpose. You confirm that We have no other obligation, liability or responsibility to You or any other party. 9. Indemnification. You will indemnify, defend and hold harmless Us and Our affiliates, officers, volunteers, employees, and agents (“Affiliates”), against any claim, damages, loss, liability, suits or expense arising out of the Your use of the Services. 10. Infringement. If you believe someone is using Your copyrighted work without Your permission on any of the Site or Content, contact info@AlzheimersQualityInitiative (Designated Copyright Agent). We will respond to claims of copyright infringement reported to Our Designated Copyright Agent in accordance with the U.S. Digital Millennium Copyright Act of 1998 (“DMCA”) or, as applicable, other laws. Notices of copyright infringement must include the following required information: Your address, telephone number, and email address; A description of the copyrighted work that You claim has been infringed; A description of where the alleged infringing material is located on the Site or Content; A statement by You that You have a good faith belief that the disputed use is not authorized by You, the copyright owner, its agent, or the law; An electronic or physical signature of the person authorized to act on behalf of the owner of the copyright interest; and A statement by You, made under penalty of perjury, that the above information is accurate and that You are the copyright owner or authorized to act on behalf of the copyright owner. 11. Conflict with Other Agreements. This Agreement applies solely to the limited purposes for which the Services are provided. You may be required to agree to other terms in other documents for other purposes in order to do business with or receive products or services from AQI not provided in this particular Service. Nothing in this Agreement is intended to conflict with or supersede the provisions of any other contract with AQI. 12. Registration. You might be asked to become a registered user (a “Registered User”) of the Site. Your approval as a Registered User is at Our discretion. Upon approval as a Registered User, You will be asked to create a password-protected account (an “Account”). You agree to keep Your Account information and password confidential. You may not share Your Account information or password with a third party. You agree to notify Us immediately of any actual or suspected unauthorized use of Your Account. You are solely responsible for all activities that occur through Your Account. We will not be responsible for any loss to You caused by Your failure to comply with these obligations. In connection with Your application to become a Registered User, You will be asked to submit certain information about yourself (“Registration Information”). You represent and warrant that: (a) all Registration Information You provide is true, accurate, current, and complete; and (b) You will maintain and promptly update the Registration Information to keep it true, accurate, current, and complete. As part of the registration process, You may be assigned or permitted to create a user ID for use in identifying Your Account (a “User ID”). You may not: (i) select or use a User ID of another person with the intent to impersonate that person; (ii) use a User ID in which another person has rights without such person’s authorization; or (iii) use a User ID that We deem offensive. Failure to comply with the foregoing will constitute a breach of this Agreement, which may result in immediate termination of Your Account. 13. Email Feature. This Website may provide certain social media features that enable Us to send electronic messages to Users through the Site. Unless You advise Us otherwise, You will receive emails and updates from time to time from Us. YOU CONSENT TO AQI SENDING YOU EMAILS AND MESSAGES. 14. Mobile Device. Your contract with Your mobile network provider (“Mobile Provider”) will continue to apply when accessing or using AQI Sites on Your mobile device (“Mobile Device”). You understand that Your Mobile Provider may charge You fees for Your use of its network while accessing or using AQI Sites, for data downloading, email, text messages, for roaming, and other Mobile Provider or third-party charges, and that YOU ARE SOLELY RESPONSIBLE FOR SUCH FEES AND CHARGES. You understand that AQI Sites are provided over the internet and mobile networks, so the quality and availability of AQI Sites may be affected by factors outside our control. We do not guarantee that this Site will be compatible or operate with Your Mobile Provider’s service plans, with any particular mobile device, or other piece of hardware, software, equipment, or device You install on or use with Your Mobile Device. We are not responsible if AQI Sites are unavailable or if You cannot download or access the content on any AQI Sites, for any compatibility or interoperability issues, or for any communication system failure which may result in AQI Sites being unavailable. 14.1. AQI may offer functionality in AQI Sites in which You may store Your log-in credentials on Your Mobile Devices, so that You can be automatically logged in each time You access AQI Sites. If someone else obtains access to Your Mobile Device (e.g., through theft), the automatic log-in feature will enable that person to have access to Your account. If Your Mobile Device is lost or stolen, it is Your responsibility to contact Your wireless carrier immediately to prevent the unauthorized use of this Site. YOU ACCEPT RESPONSIBILITY FOR ANY AQI DAMAGES RESULTING FROM SUCH UNAUTHORIZED ACCESS TO AQI SITES. 15. Miscellaneous. 15.1 This Agreement contains the entire agreement relating to the Services. No waiver or failure to enforce Our rights under this Agreement is a waiver or bar to enforcing any other of Our rights. 15.2. This Agreement is governed by the laws of the State of Pennsylvania without regard to conflict of laws provisions. You consent to the exclusive jurisdiction and venue of the courts located in Montgomery County, Pennsylvania for any action arising out of or related to this Agreement. We also agree that You or We may bring suit in court to enjoin infringement or other misuse of AQI intellectual property rights. 15.3. You acknowledge and agree that Our rights in the Site, the AQI Content and all AQI trademarks are of a unique value, the loss of which cannot be readily estimated or adequately compensated for in monetary damages. The parties specifically exclude from application to the Agreement the United Nations Convention on Contracts for the International Sale of Goods and the Uniform Computer Information Transactions Act. 15.4. You hereby irrevocably waive the right to a trial by jury. In any such dispute, the prevailing party will be entitled to recover its reasonable attorneys’ fees and expenses from the other party. Regardless of any statute or law to the contrary but to the extent this limitation is permitted by law, any claim or cause of action arising out of or related to Your use of the Site must be filed by You within one (1) year after such claim or cause of action arose or be forever barred. Your obligations under this paragraph survive termination of this Agreement. 15.5. Nonassignment. You may not assign or transfer any of Your rights under this Agreement, and any attempt to do so is null and void.15.5. Integration. This Agreement sets forth the entire understanding of the parties and supersedes any and all prior oral and written agreements or understandings between the parties regarding the subject matter of this Agreement. This Agreement may not be modified except upon written changes made by Us. The waiver by either party of a breach of any provision of this Agreement will not operate or be interpreted as a waiver of any other or subsequent breach. 15.6. Severability. If for any reason any provision of this Agreement is held invalid or unenforceable in whole or in part in any jurisdiction, such provision will, as to such jurisdiction, be deemed modified to the minimum extent necessary to make it valid and enforceable, without in any manner affecting the validity or enforceability thereof in any other jurisdiction or the remaining provisions hereof in any jurisdiction. Should any part of this Agreement be declared unlawful, void, or unenforceable, the remaining parts will remain in effect and be enforceable. 15.7. Headings and References. All references in this Agreement to Sections, paragraphs, and other subdivisions refer to the Sections, paragraphs, and other subdivisions of this Agreement unless expressly provided otherwise. Titles and headings appearing at the beginning of any subdivision are for convenience only and do not constitute any part of any such subdivision and will be disregarded in construing the language contained in this Agreement. The word “or” is not exclusive. Words in the singular form will be construed to include the plural and words in the plural form will be construed to include the singular, unless the context otherwise requires. 15.8. Modifications. AQI reserves the right, at any time and without notice, to add to, change, update, or modify the Site and the terms of use, simply by posting such addition, change, update, or modification on the website. Any such addition, change, update, or modification will be effective immediately upon posting on the website. 16.MEDICAL DISCLAIMER. YOU ACKNOWLEDGE THAT INFORMATION IS PROVIDED "AS IS" FOR GENERAL INFORMATION ONLY AND ANY ASSOCIATED DEVICE IS NOT A MEDICAL DEVICE. THE WEBSITE IS NOT INTENDED TO BE NOR IS TO BE CONSTRUED AS MEDICAL ADVICE, DIAGNOSIS, TREATMENT, OR AS A SUBSTITUTE FOR CONSULTATIONS WITH QUALIFIED HEALTH PROFESSIONALS WHO ARE FAMILIAR WITH YOUR INDIVIDUAL MEDICAL NEEDS. YOU SHOULD ALWAYS CONTACT A HEALTH CARE PROVIDER TO OBTAIN A DIAGNOSIS, TO RECEIVE INFORMATION ABOUT POTENTIAL TREATMENTS, AND TO DISCUSS ANY QUESTIONS YOU MAY HAVE ABOUT YOUR HEALTH. DO NOT DELAY IN SEEKING MEDICAL ASSISTANCE IF YOU HAVE A MEDICAL EMERGENCY. THIS IS NOT INTENDED TO BE MEDICAL SERVICES. IF YOU HAVE A MEDICAL EMERGENCY, CALL 911 OR YOUR HEALTH CARE PROVIDER. 17. Need to CONTACT AQI ? Email at AQI.Infomration@Gmail.com or mail us at Alzheimer's Quality Initiative, 207 Glenside Avenue #83, Wyncote, PA 19017. 18. Your E-Signature. USE OF THE SITE AND SERVICES ARE SUBJECT TO YOUR COMPLIANCE WITH THE TERMS SET FORTH IN ALL THE DOCUMENTS INCORPORATED INTO THE AGREEMENT. PLEASE READ THIS INFORMATION CAREFULLY. BY CLICKING “I AGREE” OR OTHERWISE SHOWING YOUR AGREEMENT (Your “E-Signature”), OR BY USING OUR SITE, YOU ARE ENTERING INTO THIS AGREEMENT ELECTRONICALLY, AND YOUR SELECTION CONSTITUTES YOUR LEGAL SIGNATURE, ACCEPTANCE AND AGREEMENT AS IF THIS AGREEMENT WERE ACTUALLY SIGNED BY YOU IN WRITING. You agree that no certification, authority, or other third-party verification is necessary to validate Your E-Signature and that the lack of such certification or third-party verification will not in any way affect the enforceability of Your E-Signature or any resulting contract between You and AQI .

Alzheimer's Center of Excellence Definition: An Alzheimer’s Center of Excellence is a clinic offering high standards of care and support for individuals living with Alzheimer’s disease and related dementias. Alzheimer’s Centers of Excellence combine clinical expertise, to help people with Alzheimer’s and other forms of dementia. These centers integrate clinical research findings, perhaps contribute to clinical research. They use disease modifying drugs in appropriate patients with speed and safety. How to Become anAlzheimer's Center of Excellence: AQI.INFORMATION@GMAIL.COM The Certification process for becoming an Alzheimer's Center of Excellence will have you meet rigorous standards, external validation, and demonstrated ongoing impact. Here’s a refined outline with real-world parallels and best practices: Key Components of a Certification Process 1. See something say something. Can your site name the disease? Do the doctors diagnose Alzheimer’s and disclose? 2. “Door to needle.” Time is brain. So what is the time between "My spouse has memory loss" and first dose of AAT? Time needed to get clinical diagnosis and stage, disclosure, imaging, BW and APOE, then biomarker confirmation. What is this process? At this point, time should be less than 90 days. Cases over 90 days should have documentation for delay (indecision among family and patient, insurance delay for biomarker, lack of follow up, unstable medical conditions, or other assorted chaos.) Slower centers require identification of barriers and delays. 3. Number of people dosed compared with your local community Best way to capture the impact of a clinic, doctor, on the disease within the population they serve. 4. Safety, monitoring, system in place for dosing. What is the system in place for ensuring compliance with: Appropriate use (not dosing people with 20 microhemes) MRI monitoring Regular clinic visits PRN problems with disease, caregivers, IRRs 5. Symptomatic mgmt. Eval for n-psych features. Use of SSRIs for anxiety, depression. ACHE-I in general, not for MCI. Memantine for late disease. Brexpiprazole for FDA approved and appropriate agitation use. Reluctance to use benzos, neuroleptics, and anti-seizure drugs in general for N-psych problems. Knowledge about and checking for anti-cholinergics. 6. Ongoing Performance Monitoring & Improvement 7. Upon certification, allow Centers to display: An official “Center of Excellence” seal. Staff credentialing as AQI-certified professionals. Accreditation status clearly on public materials and digital platforms. Welcome, listed as an AD center of excellence, invited to a webinar to share difficult cases.

We are a group of Alzheimer clinicians interested in improving care for those afflicted with AD, their families, and their doctors.

Safely Implement Anti-Amyloid Treatments Safety concerns for the new anti-amyloid therapies are such that 1) The patients should be made aware of all possible effects of the treatment and 2) Physicians and practitioners should be systematically tracking the administration of the drugs that are interspersed with regularly scheduled MRIs. Any concerns should be brought up immediately, communication is key to the success of these new therapeutics. Anti-amyloid therapies are slowing the progression of Alzheimer's dementia, but they are not without risks. The main risk is amyloid-related imaging abnormalities [ARIAs] which can be brain swelling or microhemorrhages in the brain. Because of the possible risk of ARIAs, steps need to be put in place to carefully monitor and manage the patient's progress with the treatments. There are currently 2 FDA-approved ATTs in the United States: lecanemab (Leqembi; Eisai, Nutley, NJ; accelerated approval January 2023, traditional approval July 2023) and donanemab (Kisunla; Eli Lilly, Indianapolis, IN; approved July 2024). These therapies mark a dramatic pharmacologic change for the treatment of mild cognitive impairment and mild dementia due to AD, and they have different infrastructural requirements. ATTs require a more extensive diagnostic, treatment, and monitoring process and increased participation of health care personnel compared with previous therapies (eg, acetylcholinesterase inhibitors, memantine, neuropsychiatric management). It is crucial that AD be diagnosed and disclosed in a timely manner. Initial clinical visits should focus on the clinical stage of the disease, overall health and comorbid conditions, and caregiver support. Later visits should include discussions with patients based on genetic and imaging findings, evidence of amyloid in cerebrospinal fluid samples or positron emission tomography images, and careful and thoughtful selection for therapy which requires informed patient consent. After beginning ATT therapy, individuals with AD require appropriate MRI monitoring, infusion scheduling, ARIA management, and ongoing discussions with physicians to ensure compliance, expectations, and understanding*. What is your plan to safely administer these drugs? Is it a spreadsheet? Is it an app ? Is it paper? What checklists are in place prior to the first dose? The paradigm shift associated with the emergence of ATTs has created the need for new clinical systems and workflows, interdisciplinary teams, and technical expertise for effective ATT administration. Treating physicians find themselves in various stages of motivation and readiness; however, individuals and families interested in pursuing ATT are often placed on a waiting list. In this article, we describe the components of an optimal ATT program, including workflow, staffing, oversight, and billing considerations; flexibility needs; and troubleshooting pointers. An optimal ATT program can help physicians maximize patient wellbeing, autonomy, and safety. Every program should be built for optimal flow while anticipating potential barriers which could disrupt patient care*. *Weisman, D., & Cabral, D. (2025, July 25). Building an infrastructure to administer amyloid-targeting treatments. Practical Neurology. https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/building-an-infrastructure-to-administer-amyloid-targeting-treatments/36187/

Resources We are providing extra resources to keep you informed about current best practices for Alzheimer's and Dementia treatment. You can download an editable Word Document or a PDF AQI Intake Questions Lecanemab Informed Consent PREVGEN is a Scam Letter to Patients COG Survey Follow Ups to Care Partner Donanemab Informed Consent NEURIVA is a Scam Letter to Patients Intake Survey for Memory Problems Difference Between the Two New Amyloid Therapeutics Cerefolin is a Scam Letter

Certification Benefits AQI can't help patients if we don't help those who help patients. So we pledge to never burden you with admin tasks or distractions. With certification, we encourage centers to display an "AQI Center of Excellence" seal. This is an award to all staff. Please use the accreditation status on public materials and digital platforms. Once AQI welcomes you, we will list you as an AQI center of excellence. You are invited to a webinar about difficult cases.

Copyright Policy Copyright Notice© 2024 Alzheimer’s Quality Initiative, Inc. All rights reserved. Unauthorized use prohibited.Alzheimer’s Quality Initiative copyright materials may not be reproduced in whole or in part by persons, organizations or corporations other than the AQI, its affiliates, divisions and units without the prior written permission of the AQI.The information contained in this Alzheimer’s Quality Initiative (AQI) website is not a substitute for medical advice or treatment, and the AQI recommends consultation with your doctor or health care professional. Copyright and Trademark ViolationsThe Alzheimer’s Quality Initiative takes intellectual property rights seriously. We work diligently to ensure that our works do not infringe on anyone else's rights and that others do not infringe on the AQI ‘s intellectual property rights.Visit the DMCA Notification Guidelines page for more information about how to report a copyright violation

Welcome to the Alzheimer's Quality Initiative Our mission is to improve Alzheimer's disease care. We evaluate, then coach or award based on: - Ability to diagnose and disclose Alzheimer's disease. - Timeline to treatment (Door-to-Needle time). - Number dosed in your community. - Systems for safety, monitoring, and dosing. - Appropriate symptomatic management. We will never interfere with burdensome admin metrics which distract from patient care. Those who do not trust cannot be trusted. Once certified, Alzheimer's Centers of Excellence will share case reports, disseminate ideas, and further improve clinical care. AQI Certified Centers AQI Certified Centers, recognized and certified for providing excellence in Alzheimer's care. 3) Ray Dolby Brain Health Center Sutter Health 45 Castro Street, Suite 220 San Francisco, CA 94114

Accessibility Statement The Alzheimer’s Quality Initiative strives to make our websites accessible. The Alzheimer’s Quality Initiative is committed to diversity, inclusion, and meeting the needs of all our constituents, including those with disabilities. We are continually improving our digital assets to comply with the accessibility guidelines for levels A and AA in accordance with WCAG 2.1.If the format of any material on our web pages interferes with your ability to access the information, please contact us to request assistance or if you have questions or comments about our web sites’ accessibility please call XXXXXXX for assistance.